$GNMX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aevi Genomic Medicine, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aevi Genomic Medicine, LLC. Get notifications about new insider transactions in Aevi Genomic Medicine, LLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | Chief Executive Off ... | Buy | P | 2.50 | 100,000 | 250,000 | 175,746 | 75.7 K to 175.7 K (+132.02 %) |
Feb 07 2020 | GNMX | Aevi Genomic Medic ... | ASTRAZENECA PLC | 10% Owner | Buy | P | 0.00 | 12,946,900 | 0 | 12,946,900 | 0 to 12.9 M |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 2.84 | 74,912 | 212,750 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 1.55 | 100,000 | 155,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 1.32 | 80,000 | 105,600 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 4.83 | 80,000 | 386,400 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 7.01 | 80,000 | 560,800 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 6.50 | 15,000 | 97,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 7.25 | 15,000 | 108,750 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 5.22 | 200,000 | 1,044,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 5.22 | 200,000 | 1,044,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | McInaw Michael | Interim CFO | Option Exercise | D | 1.52 | 6,500 | 9,880 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | McInaw Michael | Interim CFO | Option Exercise | D | 1.55 | 26,250 | 40,688 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | McInaw Michael | Interim CFO | Option Exercise | D | 1.32 | 5,000 | 6,600 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | McInaw Michael | Interim CFO | Option Exercise | D | 1.24 | 5,000 | 6,200 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | McInaw Michael | Interim CFO | Option Exercise | D | 4.91 | 1,500 | 7,365 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | McInaw Michael | Interim CFO | Option Exercise | D | 5.77 | 6,500 | 37,505 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | McInaw Michael | Interim CFO | Sell | D | 0.00 | 16,107 | 0 | 16,107 | 32.2 K to 16.1 K (-50.00 %) |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 2.84 | 10,591 | 30,078 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 8.09 | 40,000 | 323,600 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 4.83 | 20,000 | 96,600 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 1.32 | 20,000 | 26,400 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 1.55 | 50,000 | 77,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Sell | D | 0.00 | 59,524 | 0 | 0 | 59.5 K to 0 (-100.00 %) |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | D | 2.84 | 3,530 | 10,025 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | D | 1.55 | 50,000 | 77,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | D | 1.32 | 20,000 | 26,400 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | D | 4.83 | 20,000 | 96,600 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | D | 7.01 | 20,000 | 140,200 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | D | 6.70 | 50,000 | 335,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | D | 8.19 | 28,571 | 233,996 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Sell | D | 0.00 | 165,715 | 0 | 0 | 165.7 K to 0 (-100.00 %) |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 2.84 | 3,530 | 10,025 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 1.55 | 50,000 | 77,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 1.32 | 20,000 | 26,400 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 4.83 | 20,000 | 96,600 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 7.01 | 20,000 | 140,200 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 6.50 | 15,000 | 97,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 6.70 | 50,000 | 335,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 2.66 | 15,000 | 39,900 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 7.25 | 15,000 | 108,750 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 6.55 | 12,857 | 84,213 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | D | 8.19 | 12,857 | 105,299 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Sell | D | 0.00 | 57,536 | 0 | 0 | 57.5 K to 0 (-100.00 %) |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 2.84 | 21,181 | 60,154 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 4.22 | 1,500,000 | 6,330,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 1.32 | 50,000 | 66,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 1.55 | 661,000 | 1,024,550 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 1.51 | 450,000 | 679,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 4.91 | 250,000 | 1,227,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 4.83 | 250,000 | 1,207,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 7.01 | 292,087 | 2,047,530 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 6.45 | 17,327 | 111,759 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Sell | D | 0.00 | 2,267,859 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 1.55 | 261,000 | 404,550 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 1.51 | 300,000 | 453,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 2.84 | 13,334 | 37,869 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 1.32 | 100,000 | 132,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 4.91 | 200,000 | 982,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 4.83 | 200,000 | 966,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 7.01 | 200,000 | 1,402,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 6.45 | 13,532 | 87,281 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 4.22 | 900,000 | 3,798,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Sell | D | 0.00 | 2,164,150 | 0 | 0 | 2.2 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,267,859 | 218.5 K to 2.3 M (+938.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,267,859 | 218.5 K to 2.3 M (+938.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,164,150 | 114.8 K to 2.2 M (+1,785.58 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,164,150 | 114.8 K to 2.2 M (+1,785.58 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | S | 0.13 | 4,098,752 | 549,233 | 0 | 4.1 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | S | 0.13 | 4,098,752 | 549,233 | 0 | 4.1 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | J | 0.00 | 2,551,020 | 0 | 4,098,752 | 1.5 M to 4.1 M (+164.82 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | J | 0.00 | 2,551,020 | 0 | 4,098,752 | 1.5 M to 4.1 M (+164.82 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | J | 0.00 | 2,551,020 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | J | 0.00 | 2,551,020 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 1,547,732 | 1.2 M to 1.5 M (+30.96 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 1,547,732 | 1.2 M to 1.5 M (+30.96 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 0 | 365.9 K to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 0 | 365.9 K to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 1,181,878 | 1 M to 1.2 M (+14.97 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 1,181,878 | 1 M to 1.2 M (+14.97 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 0 | 153.8 K to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 0 | 153.8 K to 0 (-100.00 %) |
Nov 13 2018 | GNMX | Aevi Genomic Medic ... | GRANO JOSEPH J JR | Director | Buy | P | 1.15 | 21,000 | 24,150 | 56,780 | 35.8 K to 56.8 K (+58.69 %) |
Nov 13 2018 | GNMX | Aevi Genomic Medic ... | GRANO JOSEPH J JR | Director | Buy | P | 1.17 | 21,000 | 24,570 | 27,000 | 6 K to 27 K (+350.00 %) |
Nov 13 2018 | GNMX | Aevi Genomic Medic ... | GRANO JOSEPH J JR | Director | Buy | P | 1.16 | 26,000 | 30,212 | 75,683 | 49.7 K to 75.7 K (+52.33 %) |
Aug 17 2018 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 0.96 | 2,551,020 | 2,448,979 | 2,551,020 | 0 to 2.6 M |
Aug 17 2018 | GNMX | Aevi Genomic Medic ... | Children's Hospital of Philade ... | 10% Owner | Buy | P | 0.96 | 2,551,020 | 2,448,979 | 18,424,036 | 15.9 M to 18.4 M (+16.07 %) |
Jun 19 2018 | GNMX | Aevi Genomic Medic ... | Bayley Matthew D | Director | Option Exercise | A | 1.55 | 50,000 | 77,500 | 50,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 1.55 | 661,000 | 1,024,550 | 661,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 1.55 | 261,000 | 404,550 | 261,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | Piper Brian | CFO & Corporate Sec ... | Option Exercise | A | 1.55 | 238,000 | 368,900 | 238,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | GRANO JOSEPH J JR | Director | Option Exercise | A | 1.55 | 50,000 | 77,500 | 50,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | A | 1.55 | 100,000 | 155,000 | 100,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | A | 1.55 | 50,000 | 77,500 | 50,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | A | 1.55 | 50,000 | 77,500 | 50,000 | |
May 16 2018 | GNMX | Aevi Genomic Medic ... | Piper Brian | CFO & Corporate Sec ... | Option Exercise | A | 1.51 | 270,000 | 407,700 | 270,000 | |
May 16 2018 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 1.51 | 450,000 | 679,500 | 450,000 | |
May 16 2018 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 1.51 | 300,000 | 453,000 | 300,000 | |
Dec 04 2017 | GNMX | Aevi Genomic Medic ... | Bayley Matthew D | Director | Option Exercise | A | 1.25 | 40,000 | 50,000 | 40,000 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | P | 2.84 | 21,181 | 60,154 | 21,181 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Buy | P | 1.26 | 119,047 | 149,999 | 218,483 | 99.4 K to 218.5 K (+119.72 %) |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | P | 2.84 | 3,530 | 10,025 | 3,530 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Buy | P | 1.26 | 19,841 | 25,000 | 165,715 | 145.9 K to 165.7 K (+13.60 %) |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | P | 2.84 | 3,530 | 10,025 | 3,530 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Buy | P | 1.26 | 19,841 | 25,000 | 57,536 | 37.7 K to 57.5 K (+52.64 %) |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | P | 2.84 | 10,591 | 30,078 | 10,591 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Buy | P | 1.26 | 59,524 | 75,000 | 59,524 | 0 to 59.5 K |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | GANTZ WILBUR H | Director | Option Exercise | P | 2.84 | 7,061 | 20,053 | 7,061 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | GANTZ WILBUR H | Director | Buy | P | 1.26 | 39,683 | 50,001 | 71,073 | 31.4 K to 71.1 K (+126.42 %) |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | P | 2.84 | 13,344 | 37,897 | 13,344 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 1.26 | 75,000 | 94,500 | 114,774 | 39.8 K to 114.8 K (+188.57 %) |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | GRANO JOSEPH J JR | Director | Option Exercise | P | 2.84 | 7,061 | 20,053 | 7,061 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | GRANO JOSEPH J JR | Director | Sell | P | 1.26 | 39,683 | 50,001 | 98,463 | 138.1 K to 98.5 K (-28.73 %) |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | P | 2.84 | 74,912 | 212,750 | 74,912 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 1.26 | 421,032 | 530,500 | 1,028,032 | 607 K to 1 M (+69.36 %) |
Sep 06 2017 | GNMX | Aevi Genomic Medic ... | HARPER PHILIP R | 10% Owner | Buy | P | 1.20 | 83,775 | 100,530 | 4,959,819 | 4.9 M to 5 M (+1.72 %) |
Aug 24 2017 | GNMX | Aevi Genomic Medic ... | HARPER PHILIP R | 10% Owner | Buy | P | 1.20 | 5,700 | 6,840 | 4,876,044 | 4.9 M to 4.9 M (+0.12 %) |
Aug 24 2017 | GNMX | Aevi Genomic Medic ... | HARPER PHILIP R | 10% Owner | Buy | P | 1.20 | 4,661 | 5,593 | 4,870,344 | 4.9 M to 4.9 M (+0.10 %) |
Aug 15 2017 | GNMX | Aevi Genomic Medic ... | Piper Brian | CFO and Corporate S ... | Option Exercise | A | 1.32 | 380,000 | 501,600 | 380,000 | |
Aug 15 2017 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 1.32 | 400,000 | 528,000 | 400,000 | |
Aug 15 2017 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 1.32 | 500,000 | 660,000 | 500,000 | |
Aug 14 2017 | GNMX | Aevi Genomic Medic ... | HARPER PHILIP R | 10% Owner | Buy | P | 1.19 | 20,470 | 24,359 | 4,865,683 | 4.8 M to 4.9 M (+0.42 %) |
Aug 10 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | A | 1.32 | 80,000 | 105,600 | 80,000 | |
Aug 10 2017 | GNMX | Aevi Genomic Medic ... | GRANO JOSEPH J JR | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
Aug 10 2017 | GNMX | Aevi Genomic Medic ... | GANTZ WILBUR H | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
Aug 10 2017 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
Aug 10 2017 | GNMX | Aevi Genomic Medic ... | CLEMOW ALASTAIR J | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
Aug 10 2017 | GNMX | Aevi Genomic Medic ... | BAUER EUGENE A | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
May 01 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 1.57 | 100,000 | 156,670 | 607,000 | 507 K to 607 K (+19.72 %) |
Apr 27 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 1.54 | 100,000 | 154,340 | 507,000 | 407 K to 507 K (+24.57 %) |
Mar 27 2017 | GNMX | Aevi Genomic Medic ... | HARPER PHILIP R | 10% Owner | Buy | P | 1.60 | 53,826 | 86,122 | 4,845,213 | 4.8 M to 4.8 M (+1.12 %) |
Mar 27 2017 | GNMX | Aevi Genomic Medic ... | HARPER PHILIP R | 10% Owner | Buy | P | 1.60 | 4,705 | 7,528 | 4,791,387 | 4.8 M to 4.8 M (+0.10 %) |
Mar 27 2017 | GNMX | Aevi Genomic Medic ... | HARPER PHILIP R | 10% Owner | Buy | P | 1.79 | 1,000,000 | 1,790,000 | 4,786,682 | 3.8 M to 4.8 M (+26.41 %) |
Feb 17 2017 | MDGN | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 4.91 | 200,000 | 982,000 | 200,000 | |
Feb 17 2017 | MDGN | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 4.91 | 250,000 | 1,227,500 | 250,000 | |
Feb 17 2017 | MDGN | Aevi Genomic Medic ... | Piper Brian | Chief Financial Off ... | Option Exercise | A | 4.91 | 190,000 | 932,900 | 190,000 | |
Dec 12 2016 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Sell | P | 5.27 | 3,000 | 15,798 | 58,780 | 61.8 K to 58.8 K (-4.86 %) |
Apr 19 2016 | MDGN | MEDGENICS, INC. | Piper Brian | Chief Financial Off ... | Option Exercise | A | 4.83 | 150,000 | 724,500 | 150,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 4.83 | 200,000 | 966,000 | 200,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Option Exercise | A | 4.83 | 20,000 | 96,600 | 20,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | GANTZ WILBUR H | Director | Option Exercise | A | 4.83 | 20,000 | 96,600 | 20,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | Duncan Barbara Gayle | Director | Option Exercise | A | 4.83 | 20,000 | 96,600 | 20,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Option Exercise | A | 4.83 | 250,000 | 1,207,500 | 250,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J | Director | Option Exercise | A | 4.83 | 20,000 | 96,600 | 20,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Option Exercise | A | 4.83 | 20,000 | 96,600 | 20,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Option Exercise | A | 4.83 | 20,000 | 96,600 | 20,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | A | 4.83 | 80,000 | 386,400 | 80,000 | |
Apr 19 2016 | MDGN | MEDGENICS, INC. | Applebaum Scott | Chief Legal Officer | Option Exercise | A | 4.83 | 100,000 | 483,000 | 100,000 | |
Oct 08 2015 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 6.50 | 153,846 | 999,999 | 153,846 | 0 to 153.8 K |
Oct 08 2015 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Buy | P | 6.50 | 38,460 | 249,990 | 99,436 | 61 K to 99.4 K (+63.07 %) |